Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History
Wenwu He,Xuefeng Leng,Yanyu Yang,Lin Peng,Yang Shao,Xue Li,Yongtao Han
DOI: https://doi.org/10.2147/ott.s262512
IF: 4
2020-09-03
OncoTargets and Therapy
Abstract:Wenwu He, 1, * Xuefeng Leng, 1, * Yanyu Yang, 2, * Lin Peng, 1 Yang Shao, 3, 4 Xue Li, 3 Yongtao Han 1 1 Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China; 2 Department of Radiology, Dalian Medical University, Dalian, Liaoning, People's Republic of China; 3 Department of Medicine, Nanjing Geneseeq Technology, Inc, Nanjing, Jiangsu, People's Republic of China; 4 School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China *These authors contributed equally to this work Correspondence: Yongtao Han Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China Tel +86-28-85420229 Email yongtao_han@126.com Background: Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor with significant geographical variation and familial aggregation. However, the potentially different mechanisms underlying tumorigenesis in patients with ESCC with and without a family history of the disease remain unclear. In this study, the genes mutated in familial and nonfamilial ESCC were analyzed. Further, we aimed to explore the genes related to ESCC and attempt to identify potential patients in families with a history of ESCC. Methods: Next-generation sequencing technology was used to examine germline mutations and mutation profiles in 36 matched tumor-normal ESCC specimens. Additionally, tumor mutational burden (TMB) values were measured in two cohorts. Results: We identified four novel germline mutations in patients with familial ESCC, in BAX (c.121dupG: p.E41G), CDKN2A (c.374dupA: p.D125E), TP53 (c.856G>A: p.E286K), and CHEK1 (c.923+1G>A). Mutation profiles revealed that patients with and without a family history of ESCC had similar high-frequency gene mutation profiles, among which TP53 was the most commonly mutated gene. Additionally, tumor-specific mutated genes in patients with a positive family history of ESCC were APC, AKT3, DPYD, EP300, NFE2L2, PPP2R1A, RUNX1 , and VEGFA , while those in patients without a family history of ESCC were CXCR4, PIK3R2, SMARCA4 , and TTF1 . Moreover, patients with positive family history had significantly higher TMB values (7.8 ± 4.1 vs 5.0 ± 2.4, for patients with and without a family history, respectively; P = 0.038). Conclusion: Our results identified mutation profiles in patients with familial and nonfamilial ESCC, and identified germline mutations in patients with positive history. TMB values may be informative for immunotherapy approaches in familial ESCC. Keywords: esophageal squamous cell carcinoma, genetic heterogeneity, family heredity
oncology,biotechnology & applied microbiology